Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$625,410
-$186,634 QoQ
Shares Held
1,003
-4.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#751
of 1,322 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PCM Encore, LLC holds $3,460,036 across 7 Biotechnology names. REGN ranks #3 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,128 | $1,057,041 | |
| 2 | ARGX |
Argenx SE
|
682 | $632,739 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,003 | $625,410 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
26,917 | $456,781 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
3,269 | $255,864 | |
| 6 | MRNA |
Moderna, Inc.
|
3,165 | $221,644 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
6,306 | $210,557 |
All Filings in REGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $625,410 | 1,003 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $812,044 | 1,051 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $779,588 | 1,010 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||